Owner The Trustees of the University of Pennsylvania

Inventors Wilson, James M.; Gao, Guangping; Roy, Soumitra

Agent Davies Collison Cave

Pub. Number AU-A-2010202004

Parent 2007201747

Filing date 18 May 2010

Wipo publication date 10 June 2010

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 14/025 (2006.01) Peptides having more than 20 amino acids

C07K 14/075 (2006.01) Peptides having more than 20 amino acids

C07K 14/08 (2006.01) Peptides having more than 20 amino acids

C07K 14/145 (2006.01) Peptides having more than 20 amino acids

C07K 14/16 (2006.01) Peptides having more than 20 amino acids

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 7/00 (2006.01) Viruses, e.g. bacteriophages

C12N 7/04 (2006.01) Viruses, e.g. bacteriophages - Inactivation or attenuation

C12N 15/33 (2006.01) Mutation or genetic engineering - Genes encoding viral proteins

C12N 15/861 (2006.01) Mutation or genetic engineering - Adenoviral vectors

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione